Brise Pharmaceuticals Co., LTD.

Latigo

This clinical-stage biopharmaceutical company develops non-opioid medicines to treat acute and chronic pain for patients needing alternatives to addictive painkillers.

Mimetic Medicines

This company develops non-opioid peptide drug candidates for patients suffering from chronic pain.

Synerkine Pharma

This company develops fusion protein therapeutics to treat chronic pain and peripheral neuropathy for patients with inflammatory and neurodegenerative conditions.

Latigo Biotherapeutics

This clinical-stage biopharmaceutical company develops non-opioid medicines to treat patients suffering from pain without the risk of addiction.

Dolinnov

This biotechnology company develops non-opioid RNA therapies for patients suffering from severe chronic pain, including cancer and neuropathic conditions.

Labrys Biologics

This biopharmaceutical company develops monoclonal antibody therapeutics for the preventive treatment of chronic and episodic migraines in patients.

Gesynta Pharma

This company develops anti-inflammatory and pain-relieving oral pharmaceuticals targeting the mPGES-1 enzyme for patients with endometriosis and chronic inflammatory conditions.

SiteOne

This biopharmaceutical company develops selective small molecule sodium channel inhibitors to treat patients with pain, cough and other hypersensitivity disorders.